AACE

Official Twitter account for the American Association of Clinical Endocrinology (AACE). Elevating endocrinology since 1991.
Retweets ≠ endorsements.

[AACE @TheAACE]

Become an AACE Annual Meeting Abstract Reviewer!
The American Association of Clinical Endocrinology (AACE) is seeking clinicians and researchers to review scientific abstracts submitted to AACE Annual Meeting 2027. Ready to lend your expertise? Sign up by November 18! Sign up now:→ https://t.co/SUvaClRNt5

Dates to remember:
December 1- Abstract submission deadline
December 2 – 9, 2026 - Scientific abstract review period

[AACE @TheAACE]

Are you prepared to manage your diabetes in an emergency? While emergency situations are stressful and challenging for anyone, they can be potentially life-threatening to a person with a chronic medical disease such as diabetes.

Our Diabetes Emergency Plan is a convenient checklist that contains all of the essential items those with diabetes need to have readily available in the event of an emergency: https://t.co/kvdRJKbWxE.

[AACE @TheAACE]

Early-career endocrinologists: Here's your opportunity to grow as a leader and help shape the future of our specialty!

The new Daniel L. Hurley, MD, MACE AACE Emerging Leaders Initiative Award offers mentorship, leadership development, and opportunities to become more engaged in the future of endocrinology.

Be the inaugural recipient of this exciting new award and submit your self-nomination by the December 11, 2026. Learn more about the requirements here https://t.co/ypgCriE4g2

Don't miss the chance to invest in your leadership development and professional growth!

[AACE @TheAACE]

🎉 HAPPENING NOW!! 🎉

AACE is excited to be part of the 2026 Sociedad Mexicana de Nutrición y Endocrinología (SMNE) Meeting in Guadalajara! If you're attending, stop by and visit us at Table #3! We’d love to connect, share the latest AACE education and engagement opportunities, and show you how to save on AACE Community Membership and 2027 AACE Annual Meeting registration. We look forward to meeting you!

[AACE @TheAACE]

Endocrine Practice Highlight: This analysis, leveraging the safety data from ONWARDS 1-6, shows that the overall safety profiles of insulin icodec (icodec) and currently used daily basal insulins, including insulin degludec and insulin glargine, are comparable in people with type 2 diabetes or type 1 diabetes. Read more: https://t.co/p876Pfe8Eo

@vtangpricha

[AACE @TheAACE]

New in our Advocacy in Action Series: “Practical and Effective Advocacy Skills.”

AACE Past Presidents Jonathan D. Leffert, MD, MACE, FACP, ECNU, and Howard Lando, MD, MACE, FACP, discuss how endocrinologists can advocate on coverage and access barriers affecting patient care.

Listen: https://t.co/SaUX08wRBK

#WeAreAACE

[AACE @TheAACE]

Join endocrinologist Elizabeth Bauer, MD, FACP, FACE, DABOM, as she speaks with Michelle about her experience living with obesity, including the challenges, stigma, and turning points that shaped her path. Together, they explore the AACE Journey for Patients With Obesity, as Michelle shares which parts she found most helpful for understanding obesity as a chronic disease and navigating next steps. Don’t miss this inspiring discussion, brought to you with the support of Boehringer-Ingelheim, Lilly, Novo Nordisk, and Amgen.

https://t.co/jCTVT7mDMH

[AACE @TheAACE]

Many people discover that joining a support group makes living with a thyroid disorder a little easier. In the AACE Journey for Patients With Thyroid Disease your patients will find a list of support groups — and much more. Learn more at https://t.co/4BYWX9rC76 to empower them with group support and a clear path forward.

[AACE @TheAACE]

🎧 Join endocrine expert Vin Tangpricha, MD, PhD, MACE, along with Janet McGill, MD, MA, FACP, MACE, and Amy C. Donihi, PharmD, BC-ADM, FCCP, as they explore how the recently released 2026 AACE Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes builds on the 2021 guidelines to provide concise, evidence-informed recommendations for shared decision-making and practical integration of advanced glucose-sensing and insulin-delivery technologies into clinical care.

🎙️ Listen to the episode: https://t.co/TCrVqAZAlz

#WeAreAACE

[AACE @TheAACE]

Endocrine Practice Highlight: Long-Term Antithyroid Drug Therapy in the Management of Graves’ Hyperthyroidism: An Updated Narrative Review

Findings showed that patient priorities, efficacy and safety, and higher remission rates could be achieved with long-term (more than) 5 years of antithyroid drug treatment, as compared to other treatment modalities.

Read more: https://t.co/IYh4uMQgos

@vtangpricha

[AACE @TheAACE]

Osteoporosis and osteopenia are chronic conditions that significantly increase the risk of fractures both in the United States and globally. This interactive program equips health care professionals with current and emerging treatment options to improve patient outcomes in bone health. Learn more: https://t.co/gqxlTBJXgY

[AACE @TheAACE]

🎙️ New podcast episode! Vin Tangpricha, MD, PhD, MACE, moderates a discussion with Janet McGill, MD, MA, FACP, MACE, and Amy C. Donihi, PharmD, BC-ADM, FCCP, on the 2026 AACE Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes.
Listen now: https://t.co/ypx3cHgwp3

#WeAreAACE

[AACE @TheAACE]

A GPCR-specific model reduced false-positive GLP-1 receptor variant predictions by approximately 78% in validation testing, offering new possibilities for precision endocrinology.
https://t.co/4ZePmtH8en

@JohnsonThomasMD

[AACE @TheAACE]

TODAY: Complimentary Diagnosing and Managing Severe Hypertriglyceridemia in Familial Chylomicronemia Syndrome Webinar 🗓 Nov 6 | ⏰ 1–2 PM EST
• FCS vs. common hyperTG—clinical & genetic insights
• Pancreatitis risk reduction & QoL strategies
• RNA-based & team-based therapies
Endocrinologists & care teams—register before we start! 🔗 https://t.co/u5JQhIeAkj

#WeAreAACE

[AACE @TheAACE]

🚨 Today at 12 PM EST: Complimentary webinar- Diagnosis, Treatment Selection, and Monitoring of Growth Hormone Deficiency in Adults. Earn credits as experts cover diagnosis, therapy selection & monitoring. Join live 👉https://t.co/FfgRWAw05v

#WeAreAACE

[AACE @TheAACE]

For those new to injectable diabetes and obesity medications such as Ozempic (semaglutide) and Zepbound (tirzepatide), this article shares safe self-injection tips, with Dace L. Trence, MD, MACE, president of AACE, emphasizing careful vial-and-syringe techniques to avoid dosing issues from air bubbles and the need to clearly label sharps containers. Learn more tips: https://t.co/hFvfL3Ax26.

#WeAreAACE

[AACE @TheAACE]

Webinar is TOMORROW! 📅 Nov 6 | ⏰ 1–2 PM EST
Complimentary session on Diagnosing and Managing Severe Hpyertriglyceridemia in Familial Chylomicronemia:
• FCS vs. common hyperTG—clinical & genetic insights
• Pancreatitis risk reduction & QoL strategies
• RNA-based & multidisciplinary therapies
Endocrinologists & care teams—register now! 🔗 https://t.co/u5JQhIeAkj

#WeAreAACE

[AACE @TheAACE]

The AACE Patient Guide on Cushing’s Syndrome features information about this rare hormonal disorder that’s grounded in science and presented in a lay-friendly manner. Derived from AACE guidelines for clinical accuracy,
https://t.co/deMx5FWa63, share access expert-vetted information to help your patients recognize symptoms and understand treatment options.

[AACE @TheAACE]

Join our complimentary webinar on Diagnosis, Treatment Selection, and Monitoring of Growth Hormone Deficiency in Adults
📆 Tomorrow: Nov 6, 12 PM EST
• Pediatric & adult diagnosis
• Daily vs. long-acting GH therapies
• Long-term monitoring tips
Register now ▶️ https://t.co/Nnf90tOSQv

[AACE @TheAACE]

AI retinal screening sensitivity ranged from 62% to 90% across handheld-camera datasets in a new study, highlighting the need for diverse validation data.
https://t.co/NnEf0AiZM1

@JohnsonThomasMD